Early safety of tenofovir alafenamide in patients with a history of tubulopathy on tenofovir disoproxil fumarate: a randomized controlled clinical trial.
L HamzahD WilliamsA C BaileyR JonesF IbrahimC G MussoK BurlingB BarbiniL CampbellFrank A Postnull nullPublished in: HIV medicine (2019)
In people with a history of proximal renal tubulopathy while on TDF, 12-week exposure to TAF did not adversely affect renal tubular function. These data support continued evaluation of the long-term safety of TAF in this group of patients.